Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Gastrointestinal Stromal Tumors 15Neoplasms 3Colorectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Piebaldism 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Disease Progression 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Appendiceal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 17Cisplatin 12Oxaliplatin 10Cytoreduction Surgical Procedures 10Fluorouracil 9Paclitaxel 8Mitomycin 8Leucovorin 6Surgical Procedures, Operative 4Doxorubicin 3Observation 2Neoadjuvant Therapy 2Laparoscopy 2Indocyanine Green 2Docetaxel 2Control Groups 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2tremelimumab 1sodium thiosulfate 1pembrolizumab 1nilotinib 1lobaplatin 1irinotecan sucrosofate 1genexol-PM 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × nilotinib × Gastrointestinal × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡